Gene · 5420
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes. | BMC Nephrol | 2025 | 41353143 | PubTator, text mining | PubMed |
| Podocalyxin and ciliary neurotrophic factor receptor are novel components of the surfaceome of chondrogenic cells. | Cell Commun Signal | 2025 | 41327293 | PubTator, text mining | PubMed |
| Expanding the Toolbox: Novel Urinary Biomarkers for Kidney Allograft Monitoring. | Kidney360 | 2025 | 41264659 | PubTator, text mining | PubMed |
| A comprehensive review of new potential biomarkers in the detection of chronic kidney disease. | Biomarkers | 2025 | 41246886 | PubTator, text mining | PubMed |
| Podocalyxin protects high grade serous ovarian cancer spheroids from NK cell infiltration and spheroid destruction. | BMC Cancer | 2025 | 41168712 | PubTator, text mining | PubMed |
| Noninvasive assessment of classic and high PPROM using cervicovaginal podocalyxin and nephrin: Findings from a prospective observational study. | Medicine (Baltimore) | 2025 | 41137277 | PubTator, text mining | PubMed |
| Size-Modulated Mesoderm-Endoderm Divergence and Myocardial Cavitation in Micropatterned Cardioids. | bioRxiv | 2025 | 41000917 | PubTator, text mining | PubMed |
| iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis. | Stem Cell Res Ther | 2025 | 40968381 | PubTator, text mining | PubMed |
| stImage: a versatile framework for optimizing spatial transcriptomic analysis through customizable deep histology and location informed integration. | Brief Bioinform | 2025 | 40905789 | PubTator, text mining | PubMed |
| Modeling of kidney allograft rejection using hiPSC-derived kidney organoids and HLA-mismatched PBMCs: an in vitro co-culture system. | Cell Mol Life Sci | 2025 | 40892088 | PubTator, text mining | PubMed |
| CLADES: a hybrid NeuralODE-Gillespie approach for unveiling clonal cell fate and differentiation dynamics. | Nat Commun | 2025 | 40890121 | PubTator, text mining | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models. | Antibodies (Basel) | 2025 | 40843679 | PubTator, text mining | PubMed |
| Exploring the molecular mechanism of budesonide enteric capsules in the treatment of IgA nephropathy based on bioinformatics. | Sci Rep | 2025 | 40841751 | PubTator, text mining | PubMed |
| USP18 promotes ferroptosis in lipopolysaccharide-induced human kidney organoids by stabilizing STING1. | Cell Biol Toxicol | 2025 | 40833519 | PubTator, text mining | PubMed |
| Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules. | Sci Adv | 2025 | 40815665 | PubTator, text mining | PubMed |
| Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities. | Front Cell Dev Biol | 2025 | 40809695 | PubTator, text mining | PubMed |
| The endo-lysosomal system drives lumen formation in a human epiblast model. | bioRxiv | 2025 | 40799552 | PubTator, text mining | PubMed |
| Kidney-derived Urinary Extracellular Vesicles are Increased During Acute Rejection after Kidney Transplantation: A Pilot Study. | Transplant Direct | 2025 | 40746943 | PubTator, text mining | PubMed |
| Effects of Podocyte Foot Process Effacement on Kidney Prognosis and Response to Immunosuppressive Therapy in IgA Nephropathy. | Kidney Med | 2025 | 40740727 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5420/papers?page=4